CAMK2D: a novel molecular target for BAP1-deficient malignant mesothelioma.
Karnan S, Ota A, Murakami H, Rahman ML, Wahiduzzaman M, Hasan MN, Vu LQ, Hanamura I, Inoko A, Riku M, Ito H, Kaneko Y, Hyodo T, Konishi H, Tsuzuki S, Hosokawa Y.
Karnan S, et al. Among authors: murakami h.
Cell Death Discov. 2023 Jul 21;9(1):257. doi: 10.1038/s41420-023-01552-5.
Cell Death Discov. 2023.
PMID: 37479714
Free PMC article.